Among the three identified TME-based prognostic genes (LPPR4, ADAM12, NOX4), ADAM12, which was found to be overexpressed in small cell lung cancer patients, has been proven to be a potential prognostic biomarker for cancer (Iba et al., 1999). The gene discussed is ADAM12; the disease is cancer.